1 year 2.41
Extreme 2.41
3.72
3 years 0.47
Extreme 0.4701
20.4
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 23/03/2025
Chief Tech/Sci/R&D Officer - 01/09/2024
Chief Tech/Sci/R&D Officer 48 01/01/2007
Director TitleAgeSince
Chairman 52 01/01/2006
Director/Board Member 57 28/10/2024
Director/Board Member 61 28/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
20/08/25 Tax

Chief Executive Officer

5,232 0.0206%
09/06/25 Conversion

Founder

4,931,692 25.0063%
20/05/25 Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--% - - 96.4M
-1.29%-3.75%+9.43%+32.26% 117B
+2.95%+0.83%-0.69%+107.41% 97.42B
+3.31%+2.67%+123.89%+1,030.28% 59.22B
-0.20%+3.23%-5.94%+90.00% 29.03B
+8.78%+11.27%+38.72%+81.80% 26.86B
+1.26%+2.80%+37.77%+89.80% 26.69B
+2.46%-0.23%+31.22%+404.23% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +1.40%-0.16%+23.48%+207.33% 46.05B
Weighted average by Cap. +1.41%-1.33%+25.22%+220.74%
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Chrome Holding Co.